[#DIV28SUPER] NIDA Neuroscience Update June 28, 2017: New Funding Opportunities and Adolescent Brain Cognitive Development Study Announces Fast Track Data Release

 

• Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01)
  (RFA-DA-18-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21)
  (RFA-DA-18-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Advancing our Understanding of the Brain Epitranscriptome (R01)
  (PAR-17-153)
  National Institute of Mental Health
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Advancing Our Understanding of the Brain Epitranscriptome (R21)
  (PAR-17-152)
  National Institute of Mental Health
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

·         Extracellular Vesicles and Substance Use Disorders (R01)
(PAR-17-250)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

 

·         Extracellular Vesicles and Substance Use Disorders (R21)
(PAR-17-242)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

 

 

Adolescent Brain Cognitive Development Study Announces Fast Track Data Release

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

 

[#DIV28SUPER] Invitation to participate in Prescribing survey

Posted at the request of Matt Turner mturner@asppb.org: via Emily Laumeier

 

 

Association of State and Provincial Psychology Boards

 

Supporting member jurisdictions in fulfilling
their responsibility of public protection.

 

June 15, 2017

 

Dear Colleagues,

As you are likely aware, the Association of State and Provincial Psychology Boards (ASPPB) is conducting a survey of the practice of prescribing psychologists (Job Task Analysis (JTA)).  It is critical that we receive input from as many individuals that have the knowledge, skills, and experience to inform us on the current knowledge-base required for this type of practice.  Input received will determine what is measured on the Psychopharmacology Examination for Psychologist (PEP). 

If you have not already done so, please take the time to complete the survey below. 

 

https://survey.co1.qualtrics.com/jfe/form/SV_9LbSKCzNK8ZzXwN

 

Based on the experience of those who have already completed the survey, it will take only about 30 minutes or less of your time and you do not have to complete it all in one sitting.  The program remembers your progress and you can return to the spot you stopped when you have time to complete the survey.

Again, your input is very important so we hope you will consider completing this survey.  All respondents will be placed in a drawing for one of three $100 gift cards in appreciation of your participation.  The survey closes on June 26.    

 

Please pass on this link to any colleague that is trained as a prescribing psychologist even though they may not be currently prescribing. 

 

Thank you in advance,

 

Joseph E. Comaty, PhD. M.P.

Chair, PEP-Job Task Analysis Task Force (PEP-JTATF)

drscomatyadvokat@gmail.com

 

Matt Turner, PhD.

ASPPB Director of Examinations Services

mturner@asppb.org

 

 

 

 

 

 

 

 

[#DIV28SUPER] Editorial Fellowship Available for Experimental and Clinical Psychopharmacology

Dear Colleagues-
Please feel free to distribute this call to any groups or individuals who might be interested.
Thanks,
Bill Stoops
Incoming Editor, Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology will be adding an Editorial Fellow position, beginning January 1, 2018. The position is open to qualified candidates who hold the rank of Assistant Professor (or equivalent) and will last one year. During this time, the selected Fellow will work closely with the journal's Editor, Dr. William W. Stoops, to develop editorial and publishing proficiency, enrich scientific knowledge and bolster written communication skills. It is anticipated that the Fellow will manage approximately one manuscript per month. This process will include identifying reviewers, making an editorial decision based on review and shepherding the manuscript through to publication if accepted, all with guidance from Dr. Stoops. The successful candidate will also be expected to participate in monthly meetings with Dr. Stoops to ensure goals are met and problems are identified and addressed. The majority of these meetings will be phone conferences, although in-person meetings at scientific conferences are also possible. Upon successful completion of the fellowship, the Editorial Fellow will become a member of the journal's editorial board. All applications should include the following: 1) an interest statement, 2) a curriculum vitae and 3) three recommendation letters. Application materials are due to Dr. Stoops (william.stoops@uky.edu) on September 1, 2017 at 5 PM Eastern time and should be submitted as a single pdf file. Applications will be reviewed by members of the Experimental and Clinical Psychopharmacology editorial board for strength of the interest statement, research and publishing experience, manuscript review experience and enthusiasm of the recommendation letters. The top candidate will be notified of her/his selection by December 1, 2017. Address any questions to Dr. Stoops at william.stoops@uky.edu.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] New Fellows Nominations

Dear all,

Division 28 is seeking nominations for new Fellows. If you would like to nominate yourself or a colleague as a Fellow, please do so.

As described by APA, "Fellow status is an honor bestowed upon APA members who have shown evidence of unusual and outstanding contributions or performance in the field of psychology. Fellow status requires that a person's work has had a national impact on the field of psychology beyond a local, state or regional level. A high level of competence or steady and continuing contributions are not sufficient to warrant fellow status. National impact must be demonstrated."

In Division 28 a successful nominee will typically be 10-15 years post-doctorate, have a minimum of 30 publications and a track record of external funding, and can document national impact of her or his research.

If you would like to nominate a colleague for consideration for Fellow status,  please send her or his CV and contact information to the address below. You may also nominate somebody who is already an APA Fellow (with relevance to our Division), but who is not yet a Fellow of Division 28.  Self-nominations are also welcomed.

Thanks,
Matt
Contact Information for Fellow Nominations:
Matthew W. Johnson, Ph.D.
Division 28 Fellows Chair
Email: mwj@jhu.edu

--

Matthew W. Johnson, Ph.D.
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD  21224-6823
Tel: 410-550-0056
Fax: 410-550-0030
Email: mwj@jhu.edu

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] You're Invited! APA's Annual Education Advocacy Breakfast Meeting at Convention- focus on opioids

Greetings Division 28 members,

The APA Education Directorate is hosting an advocacy breakfast at the 2017 Annual Convention that will focus on the opioid epidemic. All are welcome to attend, please click the link to register. 

Warm regards,

Kelly  

 

 

 

Dana Leinbach Legislative Assistant Office of Education Government Relations Education Directorate American Psychological Association 750 First Street NE, Washington, DC 20002-4242 Tel: (202) 336-5982 Email: dleinbach@apa.org | www.apa.org

 

 

[#DIV28SUPER] 5th ANNUAL VERMONT CENTER ON BEHAVIOR AND HEALTH CONFERENCE

5^th Annual Conference: Tobacco Regulatory Science

October 5-6, 2017

Burlington Hilton Hotel

Burlington, Vermont

 

The theme of this year’s conference is Tobacco Regulatory Science, with particular focus on vulnerable populations. Regulating the nicotine content of cigarettes and other products is an important responsibility of the FDA that has tremendous potential to reduce smoking prevalence and improve the U.S. public health. Scholars from leading U.S. universities and medical centers will share their research and knowledge throughout the 2-day program. 

 

This year’s keynote speaker is Mitch Zeller, J.D., Director, Center for Tobacco Products, U.S. Food and Drug Administration. Director Zeller leads the FDA’s efforts to reduce the disease and death from tobacco use and bring previously unavailable information about its dangers to light. He is dedicated to carrying out CTP's charge to reduce the harm from all tobacco products across the entire population – with a focus on how and why people start, stop, or start again after stopping.

 

We are also announcing the call for poster abstracts in the focus area of tobacco regulatory science. Posters will be reviewed and considered on a rolling basis; abstracts will be evaluated on the basis of scientific merit. Please send submissions (including title, authors, affiliations and a 250-word abstract) to Diann Gaalema, Ph.D., at Diann.Gaalema@med.uvm.edu before July 31.

 

For conference program, registration and hotel links, please visit our website and/or conference page.

 

For general information, contact Marissa Wells at mwells@uvm.edu.

--

Stephen T. Higgins, Ph.D.

Director, Vermont Center on Behavior and Health

Virginia H. Donaldson Professor of Translational Science

Departments of Psychiatry and Psychology

Vice Chair, Department of Psychiatry

University of Vermont

1 South Prospect Street

Burlington, VT  05401-1419

VCBH Administrator: Marissa Wells
mwells2@uvm.edu

802-656-0079